---
title: "Weekly Recap | FIT HON TENG +3.93%, most brokers rate it buy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305531354.md"
description: "FIT HON TENG rose 3.93% this week to close at HK$2.645, while the Hang Seng Index fell 3.32%, leaving the stock ahead of the benchmark by about 7.25 percentage points. Across four trading days, the move was a climb and fade: Monday rallied to HK$2.680; Tuesday extended gains to HK$2.855; Wednesday touched a weekly high of HK$3.005; Thursday pulled back to HK$2.645. Weekly amplitude was 14.96%, with average daily volume of 46.2m shares, roughly double the recent median."
datetime: "2026-11-14T05:44:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305531354.md)
  - [en](https://longbridge.com/en/news/305531354.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305531354.md)
generator: "portal-rs"
---

# Weekly Recap | FIT HON TENG +3.93%, most brokers rate it buy

## The Week

FIT HON TENG (6088.HK) rose 3.93% this week to close at HK$2.645, while the Hang Seng Index fell 3.32%, leaving the stock ahead of the benchmark by about 7.25 percentage points. Across four trading days, the move was a climb and fade: Monday rallied to HK$2.680; Tuesday extended gains to HK$2.855; Wednesday touched a weekly high of HK$3.005; Thursday pulled back to HK$2.645. Weekly amplitude was 14.96%, with average daily volume of 46.2m shares, roughly double the recent median.

## Key Events

Monday morning, Morgan Stanley downgraded FIT HON TENG to Equalweight and cut its target price 55% to HK$3.6, alongside lower EPS forecasts. The stock appeared among the day’s top HK losers, but rebounded over the next two sessions, peaking at HK$3.005 on Wednesday. Thursday’s session saw the Hang Seng down more than 270 points, while semiconductor chip stocks bucked the trend. A fresh alert on Friday showed the stock down 6% intraday, but that update came after the week’s close and is not part of the weekly move.

## Analyst Ratings

As of this week, 5 brokers cover FIT HON TENG: 4 rate it buy and 1 hold, with none at under or sell. The consensus rating is strong buy, with a consensus target of HK$5.712, about 116% above the latest price. The target range is wide, from HK$3.599 to HK$7.424, pointing to meaningful dispersion among analysts. Within the electronic-components industry, the stock ranks 7th out of 14 names.

## The Week Ahead

Tuesday, 17 November, brings FIT HON TENG’s Q3 FY2026 results before the open. The same day, Hong Kong releases unemployment data; the prior reading was 3.9%. Friday, 20 November, brings CPI data, prior 1.9%. The full-year FY2026 report is scheduled for 12 March 2027, with consensus estimates of HK$0.269 EPS and HK$42.7b revenue.

## In Short

The stock gained against a weak tape, but the weekly move was a climb-and-fade pattern. Consensus rating stays strong buy and the consensus target sits more than 100% above spot, yet the target range is wide and its industry rank sits mid-pack. On the latest session, large-lot money was a net buyer while small-lot money was a net seller, a split in flows. The near-term test is the 17 November earnings print, and whether it can support the current valuation and broker expectations.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [06088.HK](https://longbridge.com/en/quote/06088.HK.md)

## Related News & Research

- [TENG: Record results and digital growth support a £100m net revenue target and 35% margin ambition](https://longbridge.com/en/news/306167367.md)
- [FIT Hon Teng Renews Five Hon Hai Transaction Frameworks](https://longbridge.com/en/news/304485355.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [Moonshot drops $150M Indonesia Nvidia rental days after US loophole crackdown](https://longbridge.com/en/news/306145817.md)
- [PRESS DIGEST-New York Times business news - November 20](https://longbridge.com/en/news/306242079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**